Close price at the end of the last trading day (Tuesday, 9th Feb 2021) of the ODT stock was $26.03. The high price target for ODT is $50.00 … Short interest in Odonate Therapeutics, Inc. (NASDAQ:ODT) saw shorts transact 4.08 Million shares and set a 0.01 days time to cover. Todos Medical is THE Biotech Company to Watch in 2021. During the day the stock fluctuated 11.10% from a day low at $19.24 to a day high … MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. appreciate its future potential. Their forecasts range from $50.00 to $50.00. … As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. It’s called. 3 stocks that may have plenty more downside, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, Receive Analysts' Upgrades and Downgrades Daily. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Copyright © 2021. Try POWR Ratings for free. • 3 Buy-Rated Value Stocks in the Technology Sector. Biotech player Todos Medical may soon rise to global recognition for its innovative testing solutions! ... 1y Target Est: 35.33: Odonate Therapeutics Inc's NA is higher than nearly none of all US stocks. Login We have 9 different ratings for every stock to help you
To see all exchange delays and terms of use please see disclaimer. You can opt out at any time. According to . Wall Street is positive on Odonate Therapeutics Inc (ODT). Description: Odonate Therapeutics Inc is a US-based pharmaceutical company that is engaged in the development … The average price target is $50.00 with a high forecast of $50.00 and a low forecast of $50.00. Want to see which stocks are moving? Zacks Investment Research - 1 year ago 4 of … Killer viruses are now a worldwide crisis and testing is imperative across the world. Will Crocs Find Institutional Support At A Key Moving Average? Based on analysts offering 12 month price targets for ODT in the last 3 months. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Odonate Therapeutics (NASDAQ: ODT) shares were trading lower on Monday after the company announced the results from CONTESSA, a Phase 3 study of Tesetaxel, achieved the primary … By April 30th, President Biden is set to sign a key policy into law… With trillions in spending expected, even billionaires like Bezos and Buffet are pouring $26 billion into one tiny corner of the market to prepare and profit. Odonate Therapeutics, Inc. (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. View real-time stock prices and stock quotes for a full financial overview. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. above. See
Learn more. risk over market), and overall volatility. The short interest in Odonate Therapeutics, Inc. (NASDAQ:ODT) is 3.24 Million shares and it means that shorts have 0.01 day (s) to cover. Just enter your email address below. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Make investment decisions regarding ODT using the data that counts. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Learn everything you need to know about successful options trading with this three-part video course. The average price target is $38.00, with a high forecast of $50.00 and a low forecast of … See what's happening in the market right now with MarketBeat's real-time news feed. The consensus price target of analysts on Wall Street is $35.33, … This is a breakdown of current recommendations and price … Odonate Therapeutics Inc () Stock Market info Recommendations: Buy or sell Odonate Therapeutics stock? Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. You can unlock it all now. 2 Wall Street analysts that have issued a 1 year ODT price target, the average ODT price target is $47.50, with the highest ODT stock price forecast at $50.00 and the lowest ODT stock price … Analyst Price Target on ODT. Ratings...FREE! 3 Wall Street analysts have issued ratings and price targets for The ODP in the last 12 months. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Odonate Therapeutics Inc's variance in analysts' estimates is less than 3.81% of all US stocks. During the day the stock fluctuated … Odonate Therapeutics Inc's number of analysts covering the stock is greater than 23.77% of Pharmaceutical Products stocks. On average, they expect Odonate Therapeutics' stock … Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . View which stocks are hot on social media with MarketBeat's trending stocks report. Identify stocks that meet your criteria using seven unique stock screeners. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. The high price target for ODP is $40.00 and the low price target for … Analyst Ratings. Use the tables below to see what analysts covering Odonate Therapeutics Inc think about its future price and what recommendations they have for investors and traders. On average, analysts give the stock a Strong Buy rating. Sign Up to See
Odonate Therapeutics, Inc. (NASDAQ:ODT)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 1.74. , 240 Short. ODT | Complete Odonate Therapeutics Inc. stock news by MarketWatch. The stock has traded … 2 Wall Street analysts have issued ratings and price targets for Odonate Therapeutics in the last 12 months. The percent of analysts bearish on the stock of ODT is less than almost 100% of all US stocks. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Fundamental company data provided by Zacks Investment Research. Odonate Therapeutics Inc (ODT) stock is trading at $18.24 as of 9:50 AM on Monday, Dec 28, an increase of $0.99, or 5.74% from the previous closing price of $17.25. odt $18.72 -$0.38 -2.0% Price as of March 3, 2021, 7:28 p.m. EST View Interactive ODT Charts Do Not Sell My Information. In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Odonate Therapeutics Inc are LJPC, SAVA and CRVS. ODT updated stock price target summary. 2 brokerages have issued 1 year price objectives for Odonate Therapeutics' shares. Dow Jones, a News Corp company About WSJ. All 'A' Rated Buy Stocks. ODT has a higher average analyst price target than 76.32% of stocks in the small market cap category. Start Your Risk-Free Trial Subscription Here, Powell: Higher inflation temporary, no rate hikes in sight, By slimmest of margins, Senate takes up $1.9T relief bill, 3 Overdone Selloffs Offering a Second Chance, Tech pulls stocks lower as bond yields continue upward march, EXPLAINER: Why rising rates are unsettling Wall Street, Stocks turn lower as bond yields continue their upward march, Shares slip in Asia after bond yield spike hits Wall St, Reading International Stock is an Under the Radar Dual Reopening Play, Kroger Stock Presents Investors With a Crisis of Conviction, Cameco Stock is the Real Deal Uranium Play, 2 Undervalued Consumer Stocks For Your Watchlist, 3 Value Stocks in Focus as Rotation Continues, On Second Thought, Investors Like What Dollar Tree Had to Say. © American Consumer News, LLC dba MarketBeat® 2010-2021. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Their average twelve-month price target is $50.00, predicting that the stock has a possible upside of 179.64%. 2 Wall Street analysts have issued ratings and price targets for Odonate Therapeutics in the last 12 months. Find the latest Odonate Therapeutics, Inc. (ODT) stock quote, history, news and other vital information to help you with your stock trading and investing. Post-Market 0.00 (0.00%) All rights reserved. Over the past 7 days, ODT's average price target has gone down $0. The dark blue line represents the company's actual price. What price target have analysts set for ODT? MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Average Target Price: 35.00: Number Of Ratings: 3: FY Report Date: 12/2020: Last Quarter's Earnings-0.93: Year Ago Earnings-4.04: Current Quarter's Estimate-0.77: Current Year's … Odonate Therapeutics Inc's average analyst price target is higher than 74.12% of stocks in the small market cap category. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Next Ex-Dividend Date: N/A. The high price target for ODT is $50.00 and the low price target for ODT is $50.00. Just click the link
Odonate Therapeutics, Inc. Common Stock (ODT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Most analysts publish their price … Odonate Therapeutics NASDAQ Updated Mar 2, 2021 10:44 PM. Please log in to your account or sign up in order to add this asset to your watchlist. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Odonate Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Odonate Therapeutics's ODT … AlTorress Sep 25, 2020. • Down 9% in 2021, is Now a Good Time to Scoop Up Pfizer Stock? • Why is Activision the Stock of the Week? © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Based on 2 analysts offering 12 month price targets for Odonate Therapeutics in the last 3 months. Comparatively, Apellis Pharmaceuticals has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Last Earnings Release: Oct. 28, 2020. This is 4.97% less than the trading day before Monday, 8th Feb 2021. Get daily stock ideas top-performing Wall Street analysts. ODT has a higher upside potential (average analyst target price relative to current price) than 85.2% of all US stocks. Get short term trading ideas from the MarketBeat Idea Engine. Join. Generally, the target price of Odonate depends on its intrinsic valuation, beta (i.e. Analysts on Wall Street suggest a consensus price … The average price target represents a 105.93% increase from the last price … Considering analysts have assigned the stock a price target range of $10-$50 as the low and high respectively, we find the trailing 12-month average consensus price target … ODT Cup-and-Handle Inverse (bearish) ODT. Looking for new stock ideas? Export data to Excel for your own analysis. Jeff Brown just released a new research report. Analyst. Zacks Investment Research raised shares of Odonate Therapeutics from a “hold” rating to a “buy” rating and set a $17.00 target price on the stock in a research note on Thursday, December 3rd. Learn about financial terms, types of investments, trading strategies and more. To see all exchange delays and terms of use, please see disclaimer. … View our full suite of financial calendars and market data tables, all for free. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy.".